Sodium Pertechnetate Tc 99M
Sodium pertechnetate Tc-99m is a radioactive technetium pertechnetate salt labeled with the metastable gamma-emitting isotope technetium-99m, used for thyroid scintigraphy, brain perfusion studies, Meckel's diverticulum detection, and as a labeling agent for numerous other technetium-99m radiopharmaceuticals. Technetium-99m emits 140 keV gamma rays with a 6-hour half-life ideal for SPECT imaging while delivering relatively low radiation dose to patients. See sodium pertechnetate for complete pharmacological details.
Moleküler Ağırlık
185,8940 g/mol
TPSA
74,30 Ų
Terapötik Alanlar
Etki Mekanizması
Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.
SMILES
[O-][99Tc](=O)(=O)=O.[Na+]
InChI
InChI=1S/Na.4O.Tc/q+1;;;;-1;/i;;;;;1+1
Molecular Formula
NaO4Tc
HBD / HBA
- / 4
Döndürülebilir Bağlar
0
Ağır Atomlar
6
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Sıkça Sorulan Sorular
Sodium pertechnetate Tc-99m is a radioactive technetium pertechnetate salt labeled with the metastable gamma-emitting isotope technetium-99m, used for thyroid scintigraphy, brain perfusion studies, Meckel's diverticulum detection, and as a labeling agent for numerous other technetium-99m radiopharmaceuticals. Technetium-99m emits 140 keV gamma rays with a 6-hour half-life ideal for SPECT imaging while delivering relatively low radiation dose to patients. See sodium pertechnetate for complete pharmacological details.
Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.
Yes, Sodium Pertechnetate Tc 99M is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2096641. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 23689036. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="sodium-pertechnetate-tc-99m"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/sodium-pertechnetate-tc-99m/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/sodium-pertechnetate-tc-99m/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/sodium-pertechnetate-tc-99m/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="sodium-pertechnetate-tc-99m"></drugfyi-drug>